Annette B. Oturai

Glostrup, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis.

Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: February 24, 2024

Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment.

Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment.

Journal: Multiple sclerosis and related disorders

Published: December 06, 2023

Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial.

Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 10, 2023

The peripheral endocannabinoid system and its association with biomarkers of inflammation in untreated patients with multiple sclerosis.

The peripheral endocannabinoid system and its association with biomarkers of inflammation in untreated patients with multiple sclerosis.

Journal: European journal of neurology

Published: March 20, 2023

The gut microbiota in multiple sclerosis varies with disease activity.

The gut microbiota in multiple sclerosis varies with disease activity.

Journal: Genome medicine

Published: May 23, 2022

The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial.

The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial.

Journal: Brain sciences

Published: August 18, 2021

MRI of the Entire Spinal Cord-Worth the While or Waste of Time? A Retrospective Study of 74 Patients with Multiple Sclerosis.

MRI of the Entire Spinal Cord-Worth the While or Waste of Time? A Retrospective Study of 74 Patients with Multiple Sclerosis.

Journal: Diagnostics (Basel, Switzerland)

Published: July 06, 2021

The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey.

The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey.

Journal: BMC neurology

Published: May 05, 2021

Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy.

Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy.

Journal: Multiple sclerosis and related disorders

Published: April 22, 2021

IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells.

IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells.

Journal: Frontiers in immunology

Published: March 04, 2021

Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patients.

Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patients.

Journal: Multiple sclerosis and related disorders

Published: February 11, 2021

Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls.

Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls.

Journal: Frontiers in immunology

Published: January 30, 2021

Showing 1-12 of 53

Last Updated: 09/26/2026